During intraday trading on Monday, GlaxoSmithKline Pharmaceuticals saw its share price shoot up by 5% to Rs 2,640 on the BSE, with a three-month high. The BSE Sensex dropped by...
Pharmaceutical industry Cipla has obtained final approval from the United States Food and Drug Administration (USFDA) for the New Drug Application (‘NDA’) it submitted for ‘Nilotinib Capsules 50, 150, and 200 mg’...
On February 19, pharmaceutical stocks faced pressure after remarks from US President Donald Trump, indicating that the US could implement tariffs close to 25% on imports of pharmaceuticals, automobiles, and semiconductors...
The maximum retail price (MRP) of medications and formulations that are no longer subject to customs duty has been adjusted by the National Pharmaceutical Pricing Authority (NPPA) in accordance with this year's budget.
In the context of ongoing US-India discussions on tariffs, key pharmaceutical industry bodies in India—Pharmaceuticals Exports Promotion Council (Pharmexcil), Indian Pharmaceutical Association (IPA), and Indian Drug Manufacturers Association (IDMA...
The government has granted a one-year extension to small and medium-sized pharmaceutical companies (with annual turnover below Rs 250 crore) to meet the revised Schedule M standards, which set quality standards and good manufacturing practices (GM...
C2 PHARMA has disclosed the approval of a Certificate of Suitability (CEP) for Oxybuprocaine Hydrochloride from the European Directorate for the Quality of Medicines and Health Care (EDQM). Oxybuprocaine Hydrochloride is presently accessible to...
Datopotamab deruxtecan (Dato-DXd) has received a recommendation for approval in the European Union (EU) to treat adult patients with unresectable or metastatic hormone receptor (HR) positive, HER2 negative (IHC 0, IHC 1+ or IHC 2+/ISH-) breast...
Bavarian Nordic A/S, a worldwide vaccine firm dedicated to enhancing health and saving lives via innovative vaccines, revealed that the Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) has issued a...
Houston-based March Biosciences, an emerging clinical stage biotechnology company committed to combating challenging cancers and other diseases, announced that the US Food and Drug Administration (FDA) granted orphan drug designation to MB-105...
, CDSCO.jpg)
